Stock listing
Cue Biopharma, Inc.
- Ticker
- Tradegate:1UC0
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Tradegate
- Currency
- EUR
Latest news from Cue Biopharma, Inc.
Cue Biopharma Announces Positive Topline Results from CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria
Sep 20, 2026
Cue Biopharma Announces Appointment of James M. Ahlers as Chief Financial Officer and CUE-221 Investigational New Drug Submission
Aug 3, 2026
Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development
Jul 13, 2026
Cue Biopharma Announces $50.0 Million Private Placement
Jul 9, 2026